Drill Pipe Market Size, Share & Trends Analysis Report By Grade (API Grade, Premium Grade), By Application (Onshore, Offshore), By Region, And Segment Forecasts, 2024 - 2030

Drill Pipe Market Size, Share & Trends Analysis Report By Grade (API Grade, Premium Grade), By Application (Onshore, Offshore), By Region, And Segment Forecasts, 2024 - 2030


Drill Pipe Market Growth & Trends

The global drill pipe market size is projected to reach USD 2,895.2 million by 2030, registering a CAGR of 3.9% over the forecast period, according to a new report by Grand View Research, Inc. Significant oilfield expansions particularly in North America and the Middle East along with improving drilling techniques with enhanced productivity have been the key factors steering industry growth over the past few years.

The global drilling activity has been steadily increasing in recent years, particularly in emerging markets. This increased drilling activity has led to higher demand for drill pipes. Moreover, Technological advancements in drilling equipment have led to the development of more efficient and effective drilling processes, which in turn has increased the demand for higher quality and more durable drill pipes.

API grade drill pipes dominated the global drill pipes market in the grade segment and accounted for more than 63.0% overall revenue share in 2022. API (American Petroleum Institute) grade drill pipes have dominated the global drill pipe market due to several factors, including their standardized design, high quality, and reliability. The API has established a set of standards for drill pipes that ensures that they meet certain specifications for size, weight, strength, and other factors. This standardization has made it easier for manufacturers to produce drill pipes that meet the needs of drilling contractors and oil and gas companies around the world.

Onshore segment dominated the application segment for the global drill pipes market and accounted for the largest revenue share of more than 60.0% in 2022. Onshore drilling is generally less expensive and easier to access than offshore drilling, which requires specialized equipment and transportation. As a result, onshore drilling is more common and widespread than offshore drilling, and thus the onshore segment has dominated the application segment for the global drill pipes market.

Drill pipes are an essential component in onshore drilling operations, and are used to transmit drilling fluid, torque, and weight to the drill bit during the drilling process. They are designed to withstand high stress and pressure, and are subject to wear and tear over time. As onshore drilling activity has increased over the years, the demand for drill pipes has grown, driving the growth of the market.

North America dominated the regional segment and accounted for the overall revenue share of more than 26.0% in 2022. North America has dominated the regional segment of the drill pipes market due to several factors, including the presence of a large number of oil and gas reserves, a well-developed oil and gas industry, and advanced drilling technologies. The United States and Canada are major players in the global oil and gas industry, with significant reserves of both conventional and unconventional oil and gas. The development of unconventional resources, such as shale gas and tight oil, has been a major driver of drilling activity in North America, leading to a surge in demand for drill pipes.

In addition, North America has a well-established infrastructure to support drilling operations, including a vast network of pipelines, storage facilities, and refineries. This infrastructure enables the efficient transportation and processing of oil and gas, further driving the demand for drill pipes. Furthermore, North America is home to some of the world's leading drilling technology companies, which have developed advanced drilling technologies and equipment, including high-quality drill pipes. This has enabled drilling companies in the region to adopt innovative drilling techniques and improve drilling efficiency, further boosting the demand for drill pipes.

Drill Pipe Market Report Highlights
  • API grade drill pipes dominated the global drill pipes market in the grade segment and accounted for more than 63.0% overall revenue share in 2023. API (American Petroleum Institute) grade drill pipes have dominated the global drill pipe market due to several factors, including their standardized design, high quality, and reliability.
  • Onshore segment dominated the application segment for the global drill pipes market and accounted for the largest revenue share of more than 60.0% in 2023. Onshore drilling is generally less expensive and easier to access than offshore drilling, which requires specialized equipment and transportation. As a result, onshore drilling is more common and widespread than offshore drilling, and thus the onshore segment has dominated the application segment for the global drill pipes market.
  • North America dominated the regional segment and accounted for the overall revenue share of more than 26.1% in 2023. North America has dominated the regional segment of the drill pipes market due to several factors, including the presence of a large number of oil and gas reserves, a well-developed oil and gas industry, and advanced drilling technologies
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Information & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Regional Outlook
Chapter 3. U.S. Dietary Supplement Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Distribution Channel Outlook
3.2.2. Manufacturing & Technology Outlook
3.2.3. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis - Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. U.S. Dietary Supplement Market: Application-End User Estimates & Trend Analysis
4.1. Application-End User Movement Analysis & Market Share, 2023 & 2030
4.2. Energy & Weight Management
4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.2.1.1. Adults
4.2.1.1.1. Male
4.2.1.1.2. Female
4.2.1.2. Geriatric
4.2.1.3. Pregnant Women
4.2.1.4. Children
4.2.1.5. Infants
4.3. General Health
4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.3.1.1. Adults
4.3.1.1.1. Male
4.3.1.1.2. Female
4.3.1.2. Geriatric
4.3.1.3. Pregnant Women
4.3.1.4. Children
4.3.1.5. Infants
4.4. Bone & Joint Health
4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.1. Adults
4.4.1.1.1. Male
4.4.1.1.2. Female
4.4.1.2. Geriatric
4.4.1.3. Pregnant Women
4.4.1.4. Children
4.4.1.5. Infants
4.5. Gastrointestinal Health
4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.5.1.1. Adults
4.5.1.1.1. Male
4.5.1.1.2. Female
4.5.1.2. Geriatric
4.5.1.3. Pregnant Women
4.5.1.4. Children
4.5.1.5. Infants
4.6. Immunity
4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.6.1.1. Adults
4.6.1.1.1. Male
4.6.1.1.2. Female
4.6.1.2. Geriatric
4.6.1.3. Pregnant Women
4.6.1.4. Children
4.6.1.5. Infants
4.7. Cardiac Health
4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.7.1.1. Adults
4.7.1.1.1. Male
4.7.1.1.2. Female
4.7.1.2. Geriatric
4.7.1.3. Pregnant Women
4.7.1.4. Children
4.7.1.5. Infants
4.8. Anti-Cancer
4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.8.1.1. Adults
4.8.1.1.1. Male
4.8.1.1.2. Female
4.8.1.2. Geriatric
4.8.1.3. Pregnant Women
4.8.1.4. Children
4.8.1.5. Infants
4.9. Diabetes
4.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.9.1.1. Adults
4.9.1.1.1. Male
4.9.1.1.2. Female
4.9.1.2. Geriatric
4.9.1.3. Pregnant Women
4.9.1.4. Children
4.9.1.5. Infants
4.10. Lung Detox/Cleanse
4.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.10.1.1. Adults
4.10.1.1.1. Male
4.10.1.1.2. Female
4.10.1.2. Geriatric
4.10.1.3. Pregnant Women
4.10.1.4. Children
4.10.1.5. Infants
4.11. Skin/Hair/Nails
4.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.11.1.1. Adults
4.11.1.1.1. Male
4.11.1.1.2. Female
4.11.1.2. Geriatric
4.11.1.3. Pregnant Women
4.11.1.4. Children
4.11.1.5. Infants
4.12. Sexual Health
4.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.12.1.1. Adults
4.12.1.1.1. Male
4.12.1.1.2. Female
4.12.1.2. Geriatric
4.12.1.3. Pregnant Women
4.12.1.4. Children
4.12.1.5. Infants
4.13. Brain/Mental Health
4.13.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.13.1.1. Adults
4.13.1.1.1. Male
4.13.1.1.2. Female
4.13.1.2. Geriatric
4.13.1.3. Pregnant Women
4.13.1.4. Children
4.13.1.5. Infants
4.14. Insomnia
4.14.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.14.1.1. Adults
4.14.1.1.1. Male
4.14.1.1.2. Female
4.14.1.2. Geriatric
4.14.1.3. Pregnant Women
4.14.1.4. Children
4.14.1.5. Infants
4.15. Menopause
4.15.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.15.1.1. Adults
4.15.1.1.1. Male
4.15.1.1.2. Female
4.15.1.2. Geriatric
4.15.1.3. Pregnant Women
4.15.1.4. Children
4.15.1.5. Infants
4.16. Anti-Aging
4.16.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.16.1.1. Adults
4.16.1.1.1. Male
4.16.1.1.2. Female
4.16.1.2. Geriatric
4.16.1.3. Pregnant Women
4.16.1.4. Children
4.16.1.5. Infants
4.17. Prenatal Health
4.17.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.17.1.1. Adults
4.17.1.1.1. Male
4.17.1.1.2. Female
4.17.1.2. Geriatric
4.17.1.3. Pregnant Women
4.17.1.4. Children
4.17.1.5. Infants
4.18. Others
4.18.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.18.1.1. Adults
4.18.1.1.1. Male
4.18.1.1.2. Female
4.18.1.2. Geriatric
4.18.1.3. Pregnant Women
4.18.1.4. Children
4.18.1.5. Infants
Chapter 5. U.S. Dietary Supplement Market: Application-ingredients Estimates & Trend Analysis
5.1. Application-ingredients Movement Analysis & Market Share, 2023 & 2030
5.2. Energy & Weight Management
5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.2.1.1. Vitamins
5.2.1.2. Botanicals
5.2.1.3. Minerals
5.2.1.4. Protein & Amino Acids
5.2.1.4.1. Collagen
5.2.1.4.2. Others
5.2.1.5. Fibers & Specialty Carbohydrates
5.2.1.6. Omega Fatty Acids
5.2.1.7. Probiotics
5.2.1.8. Others
5.3. General Health
5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.1.1. Vitamins
5.3.1.2. Botanicals
5.3.1.3. Minerals
5.3.1.4. Protein & Amino Acids
5.3.1.4.1. Collagen
5.3.1.4.2. Others
5.3.1.5. Fibers & Specialty Carbohydrates
5.3.1.6. Omega Fatty Acids
5.3.1.7. Probiotics
5.3.1.8. Others
5.4. Bone & Joint Health
5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.4.1.1. Vitamins
5.4.1.2. Botanicals
5.4.1.3. Minerals
5.4.1.4. Protein & Amino Acids
5.4.1.4.1. Collagen
5.4.1.4.2. Others
5.4.1.5. Fibers & Specialty Carbohydrates
5.4.1.6. Omega Fatty Acids
5.4.1.7. Probiotics
5.4.1.8. Others
5.5. Gastrointestinal Health
5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.1. Vitamins
5.5.1.2. Botanicals
5.5.1.3. Minerals
5.5.1.4. Protein & Amino Acids
5.5.1.4.1. Collagen
5.5.1.4.2. Others
5.5.1.5. Fibers & Specialty Carbohydrates
5.5.1.6. Omega Fatty Acids
5.5.1.7. Probiotics
5.5.1.8. Others
5.6. Immunity
5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.6.1.1. Vitamins
5.6.1.2. Botanicals
5.6.1.3. Minerals
5.6.1.4. Protein & Amino Acids
5.6.1.4.1. Collagen
5.6.1.4.2. Others
5.6.1.5. Fibers & Specialty Carbohydrates
5.6.1.6. Omega Fatty Acids
5.6.1.7. Probiotics
5.6.1.8. Others
5.7. Cardiac Health
5.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.7.1.1. Vitamins
5.7.1.2. Botanicals
5.7.1.3. Minerals
5.7.1.4. Protein & Amino Acids
5.7.1.4.1. Collagen
5.7.1.4.2. Others
5.7.1.5. Fibers & Specialty Carbohydrates
5.7.1.6. Omega Fatty Acids
5.7.1.7. Probiotics
5.7.1.8. Others
5.8. Anti-Cancer
5.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.8.1.1. Vitamins
5.8.1.2. Botanicals
5.8.1.3. Minerals
5.8.1.4. Protein & Amino Acids
5.8.1.4.1. Collagen
5.8.1.4.2. Others
5.8.1.5. Fibers & Specialty Carbohydrates
5.8.1.6. Omega Fatty Acids
5.8.1.7. Probiotics
5.8.1.8. Others
5.9. Diabetes
5.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.9.1.1. Vitamins
5.9.1.2. Botanicals
5.9.1.3. Minerals
5.9.1.4. Protein & Amino Acids
5.9.1.4.1. Collagen
5.9.1.4.2. Others
5.9.1.5. Fibers & Specialty Carbohydrates
5.9.1.6. Omega Fatty Acids
5.9.1.7. Probiotics
5.9.1.8. Others
5.10. Lung Detox/Cleanse
5.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.10.1.1. Vitamins
5.10.1.2. Botanicals
5.10.1.3. Minerals
5.10.1.4. Protein & Amino Acids
5.10.1.4.1. Collagen
5.10.1.4.2. Others
5.10.1.5. Fibers & Specialty Carbohydrates
5.10.1.6. Omega Fatty Acids
5.10.1.7. Probiotics
5.10.1.8. Others
5.11. Skin/Hair/Nails
5.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.11.1.1. Vitamins
5.11.1.2. Botanicals
5.11.1.3. Minerals
5.11.1.4. Protein & Amino Acids
5.11.1.4.1. Collagen
5.11.1.4.2. Others
5.11.1.5. Fibers & Specialty Carbohydrates
5.11.1.6. Omega Fatty Acids
5.11.1.7. Probiotics
5.11.1.8. Others
5.12. Sexual Health
5.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.12.1.1. Vitamins
5.12.1.2. Botanicals
5.12.1.3. Minerals
5.12.1.4. Protein & Amino Acids
5.12.1.4.1. Collagen
5.12.1.4.2. Others
5.12.1.5. Fibers & Specialty Carbohydrates
5.12.1.6. Omega Fatty Acids
5.12.1.7. Probiotics
5.12.1.8. Others
5.13. Brain/Mental Health
5.13.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.13.1.1. Vitamins
5.13.1.2. Botanicals
5.13.1.3. Minerals
5.13.1.4. Protein & Amino Acids
5.13.1.4.1. Collagen
5.13.1.4.2. Others
5.13.1.5. Fibers & Specialty Carbohydrates
5.13.1.6. Omega Fatty Acids
5.13.1.7. Probiotics
5.13.1.8. Others
5.14. Insomnia
5.14.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.14.1.1. Vitamins
5.14.1.2. Botanicals
5.14.1.3. Minerals
5.14.1.4. Protein & Amino Acids
5.14.1.4.1. Collagen
5.14.1.4.2. Others
5.14.1.5. Fibers & Specialty Carbohydrates
5.14.1.6. Omega Fatty Acids
5.14.1.7. Probiotics
5.14.1.8. Others
5.15. Menopause
5.15.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.15.1.1. Vitamins
5.15.1.2. Botanicals
5.15.1.3. Minerals
5.15.1.4. Protein & Amino Acids
5.15.1.4.1. Collagen
5.15.1.4.2. Others
5.15.1.5. Fibers & Specialty Carbohydrates
5.15.1.6. Omega Fatty Acids
5.15.1.7. Probiotics
5.15.1.8. Others
5.16. Anti-Aging
5.16.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.16.1.1. Vitamins
5.16.1.2. Botanicals
5.16.1.3. Minerals
5.16.1.4. Protein & Amino Acids
5.16.1.4.1. Collagen
5.16.1.4.2. Others
5.16.1.5. Fibers & Specialty Carbohydrates
5.16.1.6. Omega Fatty Acids
5.16.1.7. Probiotics
5.16.1.8. Others
5.17. Prenatal Health
5.17.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.17.1.1. Vitamins
5.17.1.2. Botanicals
5.17.1.3. Minerals
5.17.1.4. Protein & Amino Acids
5.17.1.4.1. Collagen
5.17.1.4.2. Others
5.17.1.5. Fibers & Specialty Carbohydrates
5.17.1.6. Omega Fatty Acids
5.17.1.7. Probiotics
5.17.1.8. Others
5.18. Others
5.18.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.18.1.1. Vitamins
5.18.1.2. Botanicals
5.18.1.3. Minerals
5.18.1.4. Protein & Amino Acids
5.18.1.4.1. Collagen
5.18.1.4.2. Others
5.18.1.5. Fibers & Specialty Carbohydrates
5.18.1.6. Omega Fatty Acids
5.18.1.7. Probiotics
5.18.1.8. Others
Chapter 6. U.S. Dietary Supplement Market: Form Estimates & Trend Analysis
6.1. Form Movement Analysis & Market Share, 2023 & 2030
6.2. Tablets
6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3. Capsules
6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Soft Gels
6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Powders
6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Gummies
6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.7. Liquids
6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. U.S. Dietary Supplement Market: Type Estimates & Trend Analysis
7.1. Type Movement Analysis & Market Share, 2023 & 2030
7.2. OTC
7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3. Prescribed
7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. U.S. Dietary Supplement Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Movement Analysis & Market Share, 2023 & 2030
8.2. Offline
8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.2.1.1. Hypermarkets/Supermarkets
8.2.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.2.1.2. Pharmacies
8.2.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.2.1.3. Specialty Stores
8.2.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.2.1.4. Practioners
8.2.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.2.1.5. Others
8.2.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3. Online
8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Analysis
9.1. Recent developments & impact analysis, by key market participants
9.2. Company Categorization
9.3. Participant’s Overview
9.4. Financial Performance
9.5. Application-End User Benchmarking
9.6. Company Market Share Analysis, 2023 (%)
9.7. Company Heat Map Analysis
9.8. Strategy Mapping
9.9. Company Profiles
9.9.1. Amway
9.9.1.1 Company Overview
9.9.1.2 Financial Performance
9.9.1.3 Application-End User Benchmarking
9.9.1.4 Strategic Initiatives
9.9.2. Abbott
9.9.2.1 Company Overview
9.9.2.2 Financial Performance
9.9.2.3 Application-End User Benchmarking
9.9.2.4 Strategic Initiatives
9.9.3. Bayer AG
9.9.3.1 Company Overview
9.9.3.2 Financial Performance
9.9.3.3 End User Portfolios
9.9.3.4 Strategic Initiatives
9.9.4. Glanbia plc
9.9.4.1 Company Overview
9.9.4.2 Financial Performance
9.9.4.3 Application-End User Benchmarking
9.9.4.4 Strategic Initiatives
9.9.5. Pfizer, Inc.
9.9.5.1 Company Overview
9.9.5.2 Financial Performance
9.9.5.3 Application-End User Benchmarking
9.9.5.4 Strategic Initiatives
9.9.6. Archer Daniels Midland
9.9.6.1 Company Overview
9.9.6.2 Financial Performance
9.9.6.3 Application-End User Benchmarking
9.9.6.4 Strategic Initiatives
9.9.7. GlaxoSmithKline plc
9.9.7.1 Company Overview
9.9.7.2 Financial Performance
9.9.7.3 End User Portfolios
9.9.8. NU SKIN
9.9.8.1 Company Overview
9.9.8.2 Financial Performance
9.9.8.3 Application-End User Benchmarking
9.9.8.4 Strategic Initiatives
9.9.9. Herbalife Nutrition
9.9.9.1 Company Overview
9.9.9.2 Financial Performance
9.9.9.3 Application-End User Benchmarking
9.9.9.4 Strategic Initiatives
9.9.10. Nature’s Sunshine Products, Inc.
9.9.10.1 Company Overview
9.9.10.2 Financial Performance
9.9.10.3 Application-End User Benchmarking
9.9.10.4 Strategic Initiatives
9.9.11. DuPont de Nemours Inc.
9.9.11.1 Company Overview
9.9.11.2 Financial Performance
9.9.11.3 Application-End User Benchmarking
9.9.11.4 Strategic Initiatives
9.9.12. NOW Foods
9.9.12.1 Company Overview
9.9.12.2 Financial Performance
9.9.12.3 Application-End User Benchmarking
9.9.12.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings